Abstract: Primary cutaneous amyloidosis is limited to the skin without involving any other tissue. Nodular amyloidosis is rare, and atrophic nodular cutaneous amyloidosis is even rarer. We describe the fourth case of atrophic nodular cutaneous amyloidosis by searching PubMed databases. A 52-year-old female presented to our hospital with a 2-year history of orange papules and nodules without subjective symptom on her right abdomen. Review of systems was negative. Atrophic nodular amyloidosis may progress to primary systemic disease in up to 7% of cases. Because our patient had no systemic involvement, she was diagnosed with atrophic nodular cutaneous amyloidosis based on characteristic symptoms and histopathologic examination. Routine follow-up for this patient is necessary to detect any potential disease progression.
INTRODUCTION
Amyloidosis is a group of disorders that are characterized by tissue deposition of amyloid. Primary cutaneous amyloidosis is limited to the skin without involving any other tissue. It has three major forms: macular amyloidosis, lichen amyloidosis, and, most rarely, nodular amyloidosis (NA). Atrophic nodular cutaneous amyloidosis (ANCA) in NA is even rarer.1-4 Here, we report a case of a 52-year-old woman with nodular atrophic cutaneous amyloidosis on her right abdomen.
CASE REPORT
A 52-year-old woman was followed in our dermatology clinic with a 2-year history of orange papules and nodules without subjective symptoms on her right abdomen. She recalled having had a few papules and nodules initially, that gradually increased thereafter. Before visiting our dermatology clinic, she had presented to another dermatology clinic with a diagnosis of cutaneous amyloidosis, but received no treatment. Review of systems was negative.
She had a history of diabetes, liver steatosis and gallstone surgery. 
DISCUSSION
Primary cutaneous amyloidosis is limited to the skin, and is characterized by the deposition of amyloid without involving any other tissue. Nodular amyloidosis is rare, and atrophic nodular cutaneous amyloidosis in NA is rarer1. By searching PubMed databases, there are only 3 articles that reported nodular atrophic cutaneous amyloidosis (Table 1) . [5] [6] [7] In rare cases of nodular amyloidosis, the amyloid is composed of aggregated kappa and lambda light chains, which can occasionally indicate a serious underlying systemic disease, with an estimated 7% of patients progressing to systemic amyloidosis. 1,2,5 Therefore, patients with atrophic nodular cutaneous amyloidosis should be regularly evaluated for progression. 
